Allison J. Greaney

11.7k total citations · 8 hit papers
26 papers, 4.4k citations indexed

About

Allison J. Greaney is a scholar working on Infectious Diseases, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Allison J. Greaney has authored 26 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 15 papers in Molecular Biology and 6 papers in Animal Science and Zoology. Recurrent topics in Allison J. Greaney's work include SARS-CoV-2 and COVID-19 Research (19 papers), vaccines and immunoinformatics approaches (10 papers) and Animal Virus Infections Studies (6 papers). Allison J. Greaney is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (19 papers), vaccines and immunoinformatics approaches (10 papers) and Animal Virus Infections Studies (6 papers). Allison J. Greaney collaborates with scholars based in United States, South Africa and South Korea. Allison J. Greaney's co-authors include Jesse D. Bloom, Tyler N. Starr, Adam S. Dingens, Katharine H. D. Crawford, Andrea N. Loes, David Veesler, Alexandra C. Walls, Sarah K. Hilton, Helen Y. Chu and Keara D. Malone and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Allison J. Greaney

26 papers receiving 4.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

2020 1.1k citations Tyler N. Starr, Allison J. Greaney et al. Cell profile →
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

2021 632 citations Allison J. Greaney, Andrea N. Loes et al. Cell Host & Microbe profile →
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Allison J. Greaney, Tyler N. Starr et al. Cell Host & Microbe profile →
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

2021 448 citations Tyler N. Starr, Allison J. Greaney et al. Science profile →
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016

2021 280 citations Tyler N. Starr, Allison J. Greaney et al. Cell Reports Medicine profile →
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

2021 205 citations Allison J. Greaney, Tyler N. Starr et al. Nature Communications profile →
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution

2022 157 citations Tyler N. Starr, Allison J. Greaney et al. Science profile →
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses

2022 108 citations Tyler N. Starr, Samantha K. Zepeda et al. Nature profile →

Peers

Countries citing papers authored by Allison J. Greaney

Since Specialization

Citations

This map shows the geographic impact of Allison J. Greaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison J. Greaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison J. Greaney more than expected).

Fields of papers citing papers by Allison J. Greaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison J. Greaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison J. Greaney. The network helps show where Allison J. Greaney may publish in the future.

Co-authorship network of co-authors of Allison J. Greaney

This figure shows the co-authorship network connecting the top 25 collaborators of Allison J. Greaney. A scholar is included among the top collaborators of Allison J. Greaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison J. Greaney. Allison J. Greaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies 2024 ·Cell Reports Medicine ·Daniel J. Sheward, (unknown), Hrishikesh Das, Allison J. Greaney, Chang-Il Kim, Sungyong Kim, Leo Hanke, (unknown), Robert Dyrdak, Jimin Lee, Xaquín Castro Dopico, Pia Dosenovic, Thomas P. Peacock, Gerald M. McInerney, Jan Albert, Martin Corcoran, Jesse D. Bloom, Ben Murrell, Gunilla B. Karlsson Hedestam, B.M. Hallberg	7
2	Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail 2023 ·Cell Reports ·Amin Addetia, Young‐Jun Park, Tyler N. Starr, Allison J. Greaney, Kaitlin R. Sprouse, John E. Bowen, (unknown), Wesley C. Van Voorhis, Jesse D. Bloom, Davide Corti, Alexandra C. Walls, David Veesler	7
3	Molecular fate-mapping of serum antibody responses to repeat immunization 2023 ·Nature ·Ariën Schiepers, (unknown), Allison J. Greaney, Trinity Zang, Hiromi Muramatsu, Paulo J.C. Lin, Ying K. Tam, Luka Mesin, Tyler N. Starr, Paul D. Bieniasz, Norbert Pardi, Jesse D. Bloom, Gabriel D. Victora	72
4	Influenza virus transcription and progeny production are poorly correlated in single cells 2023 ·eLife ·David J. Bacsik, Bernadeta Dadonaite, Andrew Butler, Allison J. Greaney, Nicholas S. Heaton, Jesse D. Bloom	15
5	The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution 2023 ·eLife ·Alief Moulana, Thomas Dupic, Angela M. Phillips, Jeffrey Chang, (unknown), Allison J. Greaney, Tyler N. Starr, Jesse D. Bloom, Michael M. Desai	31
6	An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain 2022 ·Virus Evolution ·Allison J. Greaney, Tyler N. Starr, Jesse D. Bloom	73
7	Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution breakdown → 2022 ·Science ·Tyler N. Starr, Allison J. Greaney, William W. Hannon, Andrea N. Loes, Kevin Hauser, Josh R. Dillen, Elena Ferri, Ariana Ghez Farrell, Bernadeta Dadonaite, Matthew McCallum, Kenneth A. Matreyek, Davide Corti, David Veesler, Gyorgy Snell, Jesse D. Bloom	157
8	Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2 2022 ·Viruses ·Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J. Greaney, Rachel Eguia, Andrea N. Loes, Nicholas Franko, Jennifer K. Logue, Juan Manuel Carreño, Anass Abbad, Helen Y. Chu, Kenneth A. Matreyek, Jesse D. Bloom	18
9	Compensatory epistasis maintains ACE2 affinity in SARS-CoV-2 Omicron BA.1 2022 ·Nature Communications ·Alief Moulana, Thomas Dupic, Angela M. Phillips, Jeffrey Chang, (unknown), (unknown), Allison J. Greaney, Tyler N. Starr, Jesse D. Bloom, Michael M. Desai	71
10	A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy 2022 ·PLoS Pathogens ·Allison J. Greaney, Tyler N. Starr, Rachel Eguia, Andrea N. Loes, Khadija Khan, Farina Karim, Sandile Cele, John E. Bowen, Jennifer K. Logue, Davide Corti, David Veesler, Helen Y. Chu, Alex Sigal, Jesse D. Bloom	28
11	The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes 2022 ·PLoS Pathogens ·Allison J. Greaney, Rachel Eguia, Tyler N. Starr, Khadija Khan, Nicholas Franko, Jennifer K. Logue, Sandra Lord, (unknown), Helen Y. Chu, Alex Sigal, Jesse D. Bloom	10
12	ACE2 binding is an ancestral and evolvable trait of sarbecoviruses breakdown → 2022 ·Nature ·Tyler N. Starr, Samantha K. Zepeda, Alexandra C. Walls, Allison J. Greaney, Sergey V. Alkhovsky, David Veesler, Jesse D. Bloom	108
13	Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 breakdown → 2021 ·Science ·Tyler N. Starr, Allison J. Greaney, Amin Addetia, William W. Hannon, Manish C. Choudhary, Adam S. Dingens, Jonathan Z. Li, Jesse D. Bloom	448
14	Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection 2021 ·Science Translational Medicine ·Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, Katharine H. D. Crawford, Tyler N. Starr, Keara D. Malone, Helen Y. Chu, Jesse D. Bloom	122
15	Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies breakdown → 2021 ·Cell Host & Microbe ·Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, Tyler N. Starr, Keara D. Malone, Helen Y. Chu, Jesse D. Bloom	632
16	Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 breakdown → 2021 ·Cell Reports Medicine ·Tyler N. Starr, Allison J. Greaney, Adam S. Dingens, Jesse D. Bloom	280
17	Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies breakdown → 2021 ·Nature Communications ·Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, Yiska Weisblum, Fabian Schmidt, Marina Caskey, Christian Gaebler, Alice Cho, Marianna Agudelo, Shlomo Finkin, Zijun Wang, Daniel Poston, Frauke Muecksch, Théodora Hatziioannou, Paul D. Bieniasz, Davide F. Robbiani, Michel C. Nussenzweig, Pamela J. Björkman, Jesse D. Bloom	205
18	Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding breakdown → 2020 ·Cell ·Tyler N. Starr, Allison J. Greaney, Sarah K. Hilton, Daniel Ellis, Katharine H. D. Crawford, Adam S. Dingens, Mary Jane Navarro, John E. Bowen, M. Alejandra Tortorici, Alexandra C. Walls, Neil P. King, David Veesler, Jesse D. Bloom	1130
19	Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition breakdown → 2020 ·Cell Host & Microbe ·Allison J. Greaney, Tyler N. Starr, Pavlo Gilchuk, Seth J. Zost, Elad Binshtein, Andrea N. Loes, Sarah K. Hilton, John Huddleston, Rachel Eguia, Katharine H. D. Crawford, Adam S. Dingens, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, Paul W. Rothlauf, Zhuoming Liu, Sean P. J. Whelan, Robert H. Carnahan, James E. Crowe, Jesse D. Bloom	568
20	A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection 2016 ·Journal of Biological Chemistry ·Catherine E. Vrentas, Mahtab Moayeri, (unknown), Allison J. Greaney, Jacqueline M. Tremblay, (unknown), Stephen H. Leppla, Charles B. Shoemaker	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact